Publications and communications of Sergio Helgueta Romero

Helgueta Romero, S., Bonafina, A., Olivié, N., Coumans, B., Nguyen, L., & Espuny Camacho, I. M. (2026). Untangling mechanisms for cerebellar neural specification using human pluripotent stem cell-derived organoids. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/345727. doi:10.64898/2026.04.27.720597

Helgueta Romero, S., Heurtaux, T., Sciortino, A., Gui, Y., Ohnmacht, J., Mencke, P., Boussaad, I., Halder, R., Garcia, P., Krüger, R., Mittelbronn, M., Buttini, M., Sauter, T., & Sinkkonen, L. (04 January 2025). Park7 deletion leads to sex-specific transcriptome changes involving NRF2-CYP1B1 axis in mouse midbrain astrocytes. NPJ Parkinson's Disease, 11 (1), 8. doi:10.1038/s41531-024-00851-7

Soriano-Baguet, L., Grusdat, M., Kurniawan, H., Benzarti, M., Binsfeld, C., Ewen, A., Longworth, J., Bonetti, L., Guerra, L., Franchina, D. G., Kobayashi, T., Horkova, V., Verschueren, C., Helgueta Romero, S., Gérard, D., More, T. H., Henne, A., Dostert, C., Farinelle, S., ... Brenner, D. (28 March 2023). Pyruvate dehydrogenase fuels a critical citrate pool that is essential for Th17 cell effector functions. Cell Reports, 42 (3), 112153. doi:10.1016/j.celrep.2023.112153

Heurtaux, T., Bouvier, D. S., Benani, A., Helgueta Romero, S., Frauenknecht, K. B. M., Mittelbronn, M., & Sinkkonen, L. (22 July 2022). Normal and Pathological NRF2 Signalling in the Central Nervous System. Antioxidants, 11 (8), 1426. doi:10.3390/antiox11081426

Colom-Cadena, M., Grau-Rivera, O., Planellas, L., Cerquera, C., Morenas, E., Helgueta Romero, S., Muñoz, L., Kulisevsky, J., Marti, M. J., Tolosa, E., Clarimon, J., Lleó, A., & Gelpi, E. (01 March 2017). Regional Overlap of Pathologies in Lewy Body Disorders. Journal of Neuropathology and Experimental Neurology, 76 (3), 216 - 224. doi:10.1093/jnen/nlx002